Navigation Links
Actavis Receives Approval of Pantoprazole Sodium Delayed-Release Tablets, USP in the U.S.
Date:2/8/2011

MORRISTOWN, N.J., Feb. 8, 2011 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Pantoprazole Sodium Delayed-Release Tablets, USP.  Distribution of the product will commence shortly.  

Pantoprazole Sodium Delayed-Release Tablets 20mg and 40mg, the generic equivalent of Protonix® 20mg and 40mg by Pfizer, had US sales of approximately $1.6 billion for the 12 months ending December 31, 2010, according to IMS Health.    

About Actavis Inc.

Actavis Inc. is the U.S. subsidiary of Actavis Group hf. Approximately one third of Actavis' sales are generated in North America, Actavis' single largest market. Based in Morristown, NJ, Actavis has U.S. manufacturing facilities in Elizabeth, NJ and Lincolnton, NC. Actavis also has research and development facilities in Owings Mills, MD and Sunrise, FL.

About Actavis Group

Actavis is one of the world's leading generic pharmaceutical companies specializing in the development, manufacture and sale of generic pharmaceuticals.  The company has operations in 40 countries, with more than 10,500 employees.

Protonix® is a trademark owned by a party other than Actavis.

Information in this press release may contain forward-looking statements with respect to the financial condition, results of operations and businesses of Actavis.  By their nature, forward-looking statements and forecasts involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from that expressed or implied by these forward-looking statements. These factors include, among other things, exchange rate fluctuations, the risk that research and development will not yield new products that ac
'/>"/>

SOURCE Actavis Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actavis Receives Approval of Alprazolam ODT in the U.S.
2. Actavis Launches Generic Version of Flomax(R) In The U.S.
3. Sagent Pharmaceuticals and Actavis Enter Into Exclusive U.S. Development, Supply and Marketing Collaboration for a Portfolio of Specialty Injectable Pharmaceutical Products
4. Actavis Receives Approval of Bupropion HCl SR 100mg and 200mg in the U.S.
5. Actavis Receives FDA Approval of Atomoxetine HCl Capsules
6. Actavis Receives Approval of Losartan Potassium Tablets, USP in the U.S.
7. Actavis Receives Approval of Zolpidem Tartrate Extended-Release Tablets, USP 6.25mg CIV in the U.S. with 180-Day Marketing Exclusivity
8. Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/h
9. Actavis Encourages Consumers to Return Fentanyl Transdermal System 25 mcg/h
10. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
11. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... MISSISSAUGA, ON , May 29, 2015 /CNW/ ... COV), an advanced medical technologies company, is delighted ... quarter ended March 31, 2015, which includes revenue ... for the quarter of $264,340. Revenue from advanced wound ... ended March 31, 2015 increased 24% to $1,742,672 ...
(Date:5/29/2015)... 29, 2015  Epic Sciences announced today that the ... metastatic castrate resistant prostate cancer patients, at the ... Clinical Oncology. This application expands the investigational utility ... platform to characterize circulating tumor cell (CTC) ... patients have heterogeneous clonal CTC populations harboring separate ...
(Date:5/29/2015)... May 29, 2015  World-renowned prostate surgeon and New York ... the benefit of MR/Ultrasound Fusion-Guided Biopsy for detecting ... Prostate Cancer Center at Lenox Hill Hospital is the ... in New York City . We,ve seen ... prostate cancers. The use of an MRI makes for a ...
Breaking Medicine Technology:Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
... enzyme that stitches all-important,molecular adjustments onto proteins contorts ... Sept. 18 St. Jude Children,s,Research Hospital investigators ... array of proteins would instantly be reduced to ... for proteins to,"accessorize" in order to regulate their ...
... Analysis Shows HUMIRA Effectively Treats Adult Patients with ... Duration of Disease, ... PARIS, Sept. 18 More psoriasis patients,achieve ... compared to patients who interrupt their therapy, according ...
Cached Medicine Technology:St. Jude Study Gives New Insights Into How Cells Accessorize Their Proteins 2St. Jude Study Gives New Insights Into How Cells Accessorize Their Proteins 3Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 2Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 3Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 4Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 5Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 6Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 7Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 8
(Date:5/30/2015)... 2015 The iconic American actor, and ... hosting a new segment on Medical Malpractice. This segment ... malpractice in the health care field. , According to ... medical malpractice suits were filed, roughly only 20% of ... out of court, while the remaining 30% were tossed ...
(Date:5/30/2015)... “ Milli the Snail ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... engages and educates children. , Interactive mobile games for children ... content and games they are playing are doing much for ...
(Date:5/30/2015)... Nevada (PRWEB) May 30, 2015 Venus ... of acne scars, large pores, deep wrinkles, stretch marks, ... licensed medical professional, such as Dr. F. Victor Rueckl ... of the clinical trials in Las Vegas. This body ... technology into a system that delivers proven results through ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 Displays and ... that has lowered the price of hanging signs ; ... Hanging signs that hang down from ceiling rigging points at ... over the trade show floor. These signs are very ... there are additional costs for installation and dismantle labor and ...
(Date:5/29/2015)... May 29, 2015 Based in St. Louis, ... awareness shirts for a couple of months now and ... latest release, which reads “I’m not misbehaving, I have Autism, ... the parent’s of an autistic child in order to start ... , Not only are they raising awareness through the autism ...
Breaking Medicine News(10 mins):Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2
... uninsured accounted for almost 1 out of 5 ... -- An estimated 50 million, or 42 percent, of ... hospital emergency departments were billed to the Medicaid and ... Thursday. , Uninsured patients accounted for nearly 18 percent ...
... , , ABA program will ... CALDWELL, N.J., July 31 Caldwell College will launch the ... (ABA), a well developed scientific discipline that is best known for ... Caldwell,s program was recently approved by the New Jersey Commission ...
... July 31 /PRNewswire-FirstCall/ - Hard to Treat Diseases,Inc. (HTDS:PK), ... MEVAC-DTaP (Diphtheria, Tetanus and Acellular,Pertussis Combined Vaccine, adsorbed) had ... The sample analysis is expected to be completed,within the ... Terry Yuan CEO of HTDS said (sic) "We welcome ...
... 31 As the world prepares for a probable ... Pittsburgh researchers are controlling the spread of infectious diseases ... (NIH) grant to establish a Center of Excellence in ... the NIH,s Modeling of Infectious Disease Agent Study (MIDAS) ...
... July 31, 2009 Raytheon Company (NYSE: RTN ... public health-led team of first responders and hospital personnel in ... information. , , The EPTS, ... of victims during mass casualty incidents by providing selected patient ...
... expect meds to relieve stress, personal troubles, researchers caution, ... growing number of Americans now have a positive opinion ... About five out of six people surveyed felt psychiatric ... also expected the medications could help people deal with ...
Cached Medicine News:Health News:ER Visits Mostly by Medicare, Medicaid Recipients 2Health News:Caldwell College Receives Approval to Launch First Ph.D. for Applied Behavior Analysis-Autism Treatment in New Jersey 2Health News:Hard to Treat Diseases, Inc. (HTDS) Thai Registration Dossier 2Health News:Hard to Treat Diseases, Inc. (HTDS) Thai Registration Dossier 3Health News:Pitt receives $13.4 million NIH grant to create virtual models for epidemics 2Health News:Raytheon to Provide California First Responders and Healthcare Personnel Electronic Patient Tracking System 2Health News:Psych Drugs Gaining Widespread Acceptance 2Health News:Psych Drugs Gaining Widespread Acceptance 3
Designed to be removed from under surgical gown without compromising sterile fields. Two straps criss-cross in the back and attach with velcro in the front....
... an elastic belt to help lift the weight ... Apron features "all around protection to cover you ... wearing and removing a breeze. For additional back ... - they reduce pressure on the vertebrae and ...
Unshielded...
... II EEG system is a fully digital 32-channel ... any practice or hospital need. It can be ... a laptop computer for out-of-lab data collection, or ... custom designed carts that will hold a high ...
Medicine Products: